Anavex Announces Appointment of Oncology Specialist to Board of Directors

Athens, Greece — May 21, 2008 — Anavex Life Sciences Corp. (“ANAVEX”) (OTC BB:AVXL) today announced the appointment of Alison Ayers to its Board of Directors. Ms. Ayers is currently the Worldwide Commercial Head for Oncology at Pfizer (NYSE:PFE), with responsibility for Pfizer’s oncology portfolio, which includes more than 20 drug candidates in clinical development,…